ANNAW
AleAnna, Inc. WarrantNASDAQ
Key Statistics
Market Cap
—
P/E Ratio
—
EPS
—
Beta
-1.20
52W High
$1.28
52W Low
$0.12
50-Day MA
$0.00
200-Day MA
$0.00
Dividend Yield
—
Profit Margin
15.80%
Forward P/E
—
PEG Ratio
—
About AleAnna, Inc. Warrant
AleAnna, Inc. Warrant (ANNAW) is a biopharmaceutical firm committed to pioneering innovative therapies that address critical unmet medical needs. The company employs advanced technologies and maintains a strong focus on research and clinical development, advancing a pipeline of unique drug candidates designed to enhance patient outcomes. With strategic partnerships in the healthcare sector, AleAnna is well-positioned to bring groundbreaking therapeutics to market, offering investors the opportunity to capitalize on the potential growth driven by its biopharmaceutical innovations.
Fundamentals
| Revenue (TTM) | $25.04M |
| Gross Profit (TTM) | $18.84M |
| EBITDA | $6.10M |
| Operating Margin | 3.81% |
| Return on Equity | 5.32% |
| Return on Assets | 2.06% |
| Revenue/Share (TTM) | $0.62 |
| Book Value | $0.87 |
| Price-to-Book | — |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | -97.10% |
| Quarterly Revenue Growth (YoY) | 1084.00% |
| Shares Outstanding | 0 |
| Float | $9.53M |
| % Insiders | 0.00% |
| % Institutions | 0.00% |
Data last updated: 4/7/2026